A year ago, they were trading at 93 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at …
While the stock has been up 16.5%, the industry gained 13.7% ... Last month, Infinity Pharmaceuticals, Inc. INFI expanded its existing clinical collaboration with Bristol-Myers Squibb BMY for evaluating IPI-549 in combination with …
The company said that no product or in-process inventory was lost and the company has enough stock to meet patient …
On Wednesday, shares in Waltham, Massachusetts headquartered ImmunoGen Inc. climbed 0.90%, ending the day at $5.59. The stock recorded a trading volume of 1.72 million shares. The Company's shares have advanced 3.14% over …
GAINERS 1. Infinity Pharmaceuticals Inc. (INFI) Gained 123.35% to close Thursday's (Oct.12) trading at $3.73. News: The Company will be reporting clinical and translational data from monotherapy dose-escalation component of its ongoing …
If you want a Stock Review on IMGN, INCY, INFI, or JAZZ then come over to http://dailystocktracker.com/register/ and …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI Keywords: Infinity …
Yahoo!6mon
It has been about a month since the last earnings report for Infinity Pharmaceuticals, Inc. INFI. Shares have lost about 5.3% in the past month, underperforming the market. Will the recent negative trend continue leading up to the stock's …
Register for free on Stock-Callers.com and download the latest research report on INFI at: http://stock